The function of these implants from billionaire Elon Musk’s company will be to “read” brain activity in order to transmit commands that help restore some severely damaged brain functions.
The Neurolink company, owned by billionaire Elon Musk, will begin human studies of its brain implants, following approval from the Food and Drug Administration (FDA). The function of this will be to “read” brain activity to transmit commands that help restore some severely damaged brain functions.
Musk indicated in early December that the company was ready to carry out these types of implants. Since then, the FDA has been concerned about possible harm these implants could do, but ultimately decided to approve the project.
“It represents an important first step that will one day allow our technology to help many people,” Neurolink said after approval.
To this day, the brain implants used have been unidirectional; that is, from the brain outwards. Instead, Musk’s company’s implants will relay the information in two directions. Therefore, they will also be able to receive a direct signal to the brain.
Its function will be to “read” brain activity in order to transmit commands that restore damaged brain functions, causing serious damage to communication.
Source: EITB
I am Mary Fitzgerald, a professional journalist and author of the Today Times Live. My specialty is in writing and reporting on technology-related topics. I have spent the last seven years extensively researching and understanding the field of technology so I can properly inform my readers about developments in this ever-evolving world.
